Verastem Oncology
VSTM
#6555
Rank
โ‚ฌ0.72 B
Marketcap
5,77ย โ‚ฌ
Share price
-7.73%
Change (1 day)
-28.20%
Change (1 year)

Earnings for Verastem Oncology (VSTM)

Earnings in 2026 (TTM): -โ‚ฌ0.18 Billion

According to Verastem Oncology 's latest financial reports the company's current earnings are โ‚ฌ87.52 Million. In 2025 the company made an earning of -โ‚ฌ0.2 Billion a decrease over its 2024 earnings that were of -โ‚ฌ0.12 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Verastem Oncology from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ0.18 Billion-9.27%
2025 -โ‚ฌ0.2 Billion60.57%
2024 -โ‚ฌ0.12 Billion49.31%
2023 -โ‚ฌ79.65 Million18.36%
2022 -โ‚ฌ67.29 Million3.67%
2021 -โ‚ฌ64.91 Million5.43%
2020 -โ‚ฌ61.57 Million-54.74%
2019 -โ‚ฌ0.14 Billion105.99%
2018 -โ‚ฌ66.04 Million6.83%
2017 -โ‚ฌ61.81 Million86.06%
2016 -โ‚ฌ33.22 Million-37.03%
2015 -โ‚ฌ52.75 Million8.43%
2014 -โ‚ฌ48.65 Million29.52%
2013 -โ‚ฌ37.56 Million28.6%
2012 -โ‚ฌ29.21 Million133.9%
2011 -โ‚ฌ12.49 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚ฌ6.35 B-3,551.52%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚ฌ1.32 B-820.72%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚ฌ6.52 B-3,643.89%๐Ÿ‡ฌ๐Ÿ‡ง UK
Curis
CRIS
-โ‚ฌ7.71 Million-95.82%๐Ÿ‡บ๐Ÿ‡ธ USA